Estructura del grupo
14 empresas en 11 países
14 empresas en 11 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 184
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ACID CONCENTRATE 21568.11 g / l + 6.24 g / l + 90 g / l + 3.21 g / l + 10.1 g / l + 268 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1999 |
| ACID CONCENTRATE 218210.81 g / l + 6.24 g / l + 89.99 g / l + 1.61 g / l + 10.06 g / l + 262.98 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1220110.8 g / l + 6.24 g / l + 45 g / l + 1.61 g / l + 10.1 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1989 |
| ACID CONCENTRATE D1220710.8 g / l + 7.49 g / l + 45 g / l + 2.14 g / l + 10.05 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1990 |
| ACID CONCENTRATE D1223610.8 g / l + 6.24 g / l + 67.5 g / l + 3.21 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1224810.8 g / l + 7.49 g / l + 90 g / l + 1.61 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1995 |
| ACID CONCENTRATE D1226210.8 g / l + 7.49 g / l + 90 g / l + 1.61 g / l + 3.35 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1995 |
| ACID CONCENTRATE D122645.41 g / l + 6.24 g / l + 45 g / l + 2.14 g / l + 5.02 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1995 |
| ACID CONCENTRATE D1227210.8 g / l + 7.49 g / l + 45 g / l + 2.14 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1227510.8 g / l + 6.24 g / l + 45 g / l + 1.61 g / l + 3.35 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1228610.8 g / l + 6.24 g / l + 45 g / l + 1.61 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1229010.8 g / l + 7.48 g / l + 90 g / l + 1.61 g / l + 10 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1229110.8 g / l + 6.24 g / l + 90 g / l + 1.61 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1229310.8 g / l + 6.24 g / l + 45 g / l + 2.14 g / l + 10 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1229410.8 g / l + 6.24 g / l + 45 g / l + 2.14 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1229910.8 g / l + 6.24 g / l + 67.5 g / l + 3.21 g / l + 5.02 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1230010.8 g / l + 6.24 g / l + 45 g / l + 2.14 g / l + 3.35 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1230210.8 g / l + 4.99 g / l + 45 g / l + 2.14 g / l + 3.35 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1230510.8 g / l + 4.99 g / l + 67.5 g / l + 2.14 g / l + 6.7 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| ACID CONCENTRATE D1231610.8 g / l + 6.24 g / l + 90 g / l + 1.61 g / l + 3.35 g / l + 263 g / l · Solution | Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1996 |
| BICARBONATE CONCENTRATE D1700081.3 g / l · Solution | Bicarbonate | Canadá | Comercializado | 1986 |
| BICART1250 g / cartridge · Powder | Bicarbonate | Canadá | Comercializado | 2013 |
| BICART720 g / cartridge · Powder | Bicarbonate | Canadá | Comercializado | 2013 |
| BICART POWDER FOR HAEMODIALYSIS100% · Powder, for solution | Bicarbonate | Singapur | Autorizado | 1991 |
| BICART SELECT COMBI-PAK720 g / cartridge + 1200 g / cartridge · Kit, Powder For Solution | Bicarbonate, Sodium chloride | Canadá | Comercializado | 2016 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 60 | 60 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 37 | 37 | 0 | EmpresasTodos los medicamentos |
| España | 29 | 25 | 4 | EmpresasTodos los medicamentos |
| Países Bajos | 24 | 24 | 0 | EmpresasTodos los medicamentos |
| Croacia | 19 | 19 | 0 | EmpresasTodos los medicamentos |
| Singapur | 15 | 15 | 0 | EmpresasTodos los medicamentos |
También en los registros de Colombia, Francia, Italia, Malasia, Reino Unido, Serbia, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licencia: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Vantive en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaLicencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licencia: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licencia: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.